SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-125935
Filing Date
2021-10-14
Accepted
2021-10-13 20:29:37
Documents
16
Period of Report
2021-10-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2129696d6_8k.htm   iXBRL 8-K 38232
2 EXHIBIT 1.1 tm2129696d6_ex1-1.htm EX-1.1 244312
3 EXHIBIT 5.1 tm2129696d6_ex5-1.htm EX-5.1 76706
8 GRAPHIC tm2129696d6_ex5-1img001.jpg GRAPHIC 8111
  Complete submission text file 0001104659-21-125935.txt   671418

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bcyc-20211012.xsd EX-101.SCH 3731
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcyc-20211012_def.xml EX-101.DEF 27311
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcyc-20211012_lab.xml EX-101.LAB 37339
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcyc-20211012_pre.xml EX-101.PRE 25936
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2129696d6_8k_htm.xml XML 5372
Mailing Address B900 BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address B900 BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 011441223261503
BICYCLE THERAPEUTICS plc (Filer) CIK: 0001761612 (see all company filings)

IRS No.: 000000000
Type: 8-K | Act: 34 | File No.: 001-38916 | Film No.: 211322312
SIC: 2834 Pharmaceutical Preparations